Federal prosecutors recently announced a $12.6 million False Claims Act (FCA) settlement with a major New Jersey health system to resolve allegations that the system paid outside physicians in order to increase referrals.

The settlement results from a whistleblower lawsuit filed in the U.S. District Court for the District of New Jersey under the qui tam provisions of the federal and New Jersey state false claims acts. The federal FCA grants a cause of action to the United States and qui tam relators against any entity that makes a fraudulent claim for payment to the federal government, and provides for treble damages, civil penalties, expenses, costs, and attorney fees. The New Jersey statute, which was enacted in 2008, models the federal law.

The whistleblower, a cardiologist outside of the health system, claimed that between October 1, 2004, and December 31, 2010, the health system paid physicians $18,500 per year to serve on one of its advisory boards, but actually used board meetings to induce referrals to the health system. The lawsuit specifically alleged that the health system violated anti-kickback laws and both New Jersey and federal self-referral laws. This allegedly resulted in false claims for Medicare and Medicaid payments being submitted to the State of New Jersey and the U.S. government.

Under the agreement, the health system admitted no wrongdoing and has since enacted reforms to enhance accountability and training. Specifically, the health system must pay $10,269,000 to the United States and $2,331,000 to the State of New Jersey. From those funds, the whistleblower will receive $2,394,000. The health system also must pay $430,000 in fees and costs to the whistleblower’s counsel.

In addition, under the agreement, the Office of Inspector General of the Department of Health and Human Services expressly reserved its rights to bring an administrative action seeking exclusion of the health system and/or its officers, trustees, and employees from federal health care programs, including Medicare and Medicaid. The agreement did not release the health system from potential criminal liability or liability arising under state or federal revenue codes.

This settlement demonstrates the complex regulatory environment in which health care clients operate, as well as the substantial financial consequences that may arise from alleged FCA violations. 

Ballard Spahr attorneys in the Health Care and White Collar/Investigations practice groups have extensive experience with state and federal false claims acts, and in advising clients on appropriate compliance measures. For more information, please contact Health Care Practice Leader Jean C. Hemphill at 215.864.8539 or hemphill@ballardspahr.com, White Collar/Investigations Practice Leader Henry E. Hockeimer, Jr. at 215.864.8204 or hockeimerh@ballardspahr.com, Dee Spagnuolo at 215.864.8312 or spagnuolod@ballardspahr.com, or the Ballard Spahr attorney with whom you work. 

Copyright © 2013 by Ballard Spahr LLP.
(No claim to original U.S. government material.)

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, including electronic, mechanical, photocopying, recording, or otherwise, without prior written permission of the author and publisher.

This alert is a periodic publication of Ballard Spahr LLP and is intended to notify recipients of new developments in the law. It should not be construed as legal advice or legal opinion on any specific facts or circumstances. The contents are intended for general informational purposes only, and you are urged to consult your own attorney concerning your situation and specific legal questions you have.

Related Practices

Health Care
White Collar Defense/Internal Investigations